The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Macrophage-tumor chimeric exosomes accumulate in lymph node and tumor to activate the immune response and the tumor microenvironment
Abstract
Macrophage-tumor chimeric exosomes inhibit tumor growth in multiple mouse models by stimulating the immune response and tumor microenvironment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“They harnessed macrophages to create immune-stimulated macrophage-tumor hybrid cells, and the chimeric extracellular vesicles from them have dual-targeting and combined mechanisms to enhance the immune response and immunotherapy outcomes.”
From Emerging role of exosomes in cancer therapy: progress and challenges (2025) · cites this paper as [191]
In the citing paper
“The study showed that these chimeric exosomes effectively slowed tumor development within multiple animal tumor models, involving lymphoma, outperforming the performance of traditional tumor vaccines and T-cell re-infusion treatments [191].”
From Emerging role of exosomes in cancer therapy: progress and challenges (2025) · cites this paper as [191]
In the citing paper
“| Lymphoma | Dual-targeting exosomes | Effectively slowed tumor progression across various animal tumor models, including lymphoma, surpassing the performance of traditional tumor vaccines and T-cell reinfusion therapies | [191] |”
From Emerging role of exosomes in cancer therapy: progress and challenges (2025) · cites this paper as [191]
Citations
Cites
Universal sample preparation method for proteome analysis
Wiśniewski, J. R., Zougman, A., Nagaraj, N., & Mann, M. (2009) · Nature Methods · doi:10.1038/nmeth.1322 · Cited by 8,352
Cancer immunotherapy using checkpoint blockade
Ribas, A., & Wolchok, J. D. (2018) · Science · doi:10.1126/science.aar4060 · Cited by 6,791
Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids
Théry, C., Amigorena, S., Raposo, G., & Clayton, A. (2006) · Current Protocols in Cell Biology · doi:10.1002/0471143030.cb0322s30 · Cited by 5,766
Innate and adaptive immune cells in the tumor microenvironment
Gajewski, T. F., Schreiber, H., & Fu, Y.-X. (2013) · Nature Immunology · doi:10.1038/ni.2703 · Cited by 4,148
Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver
Costa-Silva, B., Aiello, N. M., Ocean, A. J., Singh, S., Zhang, H., Thakur, B. K., Becker, A., Hoshino, A., Mark, M. T., Molina, H., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3169 · Cited by 2,692
Regulation of immune responses by extracellular vesicles
Robbins, P. D., & Morelli, A. E. (2014) · Nature Reviews Immunology · doi:10.1038/nri3622 · Cited by 2,260
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
Gordon, S. R., Maute, R. L., Dulken, B. W., Hutter, G., George, B. M., McCracken, M. N., Gupta, R., Tsai, J. M., Sinha, R., Corey, D., et al. (2017) · Nature · doi:10.1038/nature22396 · Cited by 2,247
Patient-derived organoids model treatment response of metastatic gastrointestinal cancers
Vlachogiannis, G., Hedayat, S., Vatsiou, A., Jamin, Y., Fernández-Mateos, J., Khan, K., Lampis, A., Eason, K., Huntingford, I., Burke, R., et al. (2018) · Science · doi:10.1126/science.aao2774 · Cited by 2,096
Couzin-Frankel, J. (2013) · Science · doi:10.1126/science.342.6165.1432 · Cited by 2,051 · cited 1×
“INTRODUCTION Cancer immunotherapies boost or harness the immune system of the body to battle tumor cells (1).”
BackgroundZhang, Y., Bi, J., Huang, J., Tang, Y., Du, S., & Li, P. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s264498 · Cited by 1,323
Flagged first, then by citations
Research works printed but not linked: 60
- 10.1016/j.cell.2017.12.002 · DOI
- 10.1038/s41591-018-0040-8 · DOI
- 10.1038/s41563-018-0028-2 · DOI
- 10.1021/nn900715g · DOI
- 10.1038/nbt.3071 · DOI
- 10.1038/nmat4822 · DOI
- 10.1038/nrc1586 · DOI · Paper page
- 10.1038/nature19364 · DOI
- 10.1111/j.1365-2249.2012.04657.x · DOI
- 10.1016/j.cell.2006.01.007 · DOI
- 10.1158/0008-5472.CAN-18-1351 · DOI · Paper page
- 10.1038/nrc1256 · DOI
- 10.1038/nri855 · DOI
- 10.1038/s41556-018-0250-9 · DOI
- 10.1172/JCI81137 · DOI · Paper page
- 10.1016/j.ymthe.2017.02.007 · DOI
- 10.1182/blood-2007-03-079152 · DOI
- 10.1021/acsnano.8b02446 · DOI
- 10.1002/adma.201506086 · DOI
- 10.1038/s41929-019-0333-4 · DOI
- 10.1073/pnas.1100446108 · DOI · Paper page
- 10.1002/eji.1830060713 · DOI
- 10.1158/1078-0432.CCR-05-1330 · DOI
- 10.1038/nm0597-558 · DOI
- 10.4161/onci.24437 · DOI
- 10.1016/j.cell.2019.02.029 · DOI · Paper page
- 10.1126/sciadv.aat7828 · DOI
- 10.1158/0008-5472.CAN-10-3223 · DOI
- 10.1159/000486814 · DOI
- 10.1073/pnas.0610731104 · DOI · Paper page
- 10.1016/j.it.2013.02.003 · DOI
- 10.1073/pnas.1209100109 · DOI · Paper page
- 10.1038/nbt1332 · DOI
- 10.1038/s41578-019-0110-7 · DOI
- 10.1038/nm0598-594 · DOI
- 10.1182/blood-2005-01-0220 · DOI
- 10.1016/j.cell.2011.02.013 · DOI · Paper page
- 10.1038/nri3789 · DOI · Paper page
- 10.1038/nrc.2017.6 · DOI · Paper page
- 10.1038/nm.2753 · DOI · Paper page
- 10.1016/j.ccell.2016.06.021 · DOI
- 10.1126/scitranslmed.aan3682 · DOI
- 10.1021/acsnano.8b00204 · DOI
- 10.1158/0008-5472.CAN-16-3431 · DOI
- 10.1126/science.aar7112 · DOI
- 10.1158/0008-5472.CAN-20-2990 · DOI · Paper page
- M. Cybula, K. Moxley, L. Wang, L. Y. Wang, M. Bieniasz, Utilization of patient-derived tumor xenograft (Pdx) models in oncology. Clin. Cancer Res. 25, 84–84 (2019). · DOI
- 10.1080/07388551.2020.1805406 · DOI
- 10.1126/scitranslmed.aaz1723 · DOI
- 10.1038/ncomms14537 · DOI
- 10.1038/nmat5057 · DOI
- 10.1002/advs.202001108 · DOI
- 10.1073/pnas.1106634108 · DOI
- 10.1016/S1074-7613(02)00365-5 · DOI
- 10.1111/j.1365-2249.2005.02868.x · DOI
- 10.1038/s42003-020-01466-3 · DOI
- 10.1074/jbc.M115.636506 · DOI
- 10.1038/s41467-020-20154-8 · DOI
- 10.1158/0008-5472.CAN-15-1625 · DOI
- 10.1016/j.celrep.2014.07.035 · DOI · Paper page
Cited by
Sorted by citations
Recent advances in exosome-mediated nucleic acid delivery for cancer therapy
Zhang, Y., Liu, Q., Zhang, X., Huang, H., Tang, S., Chai, Y., Xu, Z., Li, M., Chen, X., Liu, J., et al. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01472-z · Cited by 306
Emerging role of exosomes in cancer therapy: progress and challenges
Li, J., Wang, J., & Chen, Z. (2025) · Molecular Cancer · doi:10.1186/s12943-024-02215-4 · Cited by 297
Self-citationBreaking Boundaries: Chronic Diseases and the Frontiers of Immune Microenvironments
Li, G., Wan, Y., Jiao, A., Jiang, K., Cui, G., Tang, J., Yu, S., Hu, Z., Zhao, S., Yi, Z., et al. (2025) · Med Research · doi:10.1002/mdr2.70007 · Cited by 63
Metadata
- Authors
- Wang, S., Li, F., Ye, T., Wang, J., Lyu, C., Qing, S., Ding, Z., Gao, X., Jia, R., Yu, D., Ren, J., Wei, W., & Ma, G.
- Venue
- Science Translational Medicine
- Published
- 2021-10-13
- Volume
- 13
- Issue
- 615
- ISSN
- 1946-6234
- 1946-6242
- Cited by
- 240
- References
- 11
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review